Industrial commentary by Dr. Rene Holm on bridging the gaps between academic research and industrial drug product developments in Advanced drug delivery reviews
PEARRL's Dr. Rene Holm (Jannsen) recently published a review in Advanced Drug Delivery Reviews highlighting the importance of joint academia-industry research consortia, such as PEARRL, for advancing innovation in the pharmaceutical drug development field. Dr. Holm gives examples of where academia and industry have successfully collaborated withing large multi-partner networks to produce major advances in scientific understanding and novel drug delivery technologies. He also highlights the importance that all stakeholders in the the Pharmaceutical ecosystem (figure insert), including academia, industry, CRO's, service/technology providers, etc., are involved in such consortia, so that new technological advances meets the needs of the various stakeholders, including patients, regulators and industry. Finally he emphasizes the need that future funding calls for similar academic-industry consortia focusing on addressing 'gaps in academic research and the needs of industrial product development' and sharing the data so all stakeholders can benefit. The full article can be accessed here R. Holm, Bridging the gaps between academic research and industrial product developments ..., Adv.Drug Deliv. Rev., https://doi.org/10.1016/j.addr.2019.01.009
PEARRL publishes an open access special issue of J. Pharm. Pharmacol. on approaches for accelerating R&D for faster #accesstomedicines
In February 2019, the PEARRL network published a special 'PEARRL themed' issue in Journal of Pharmacy & Pharmacology on innovative drug development strategies tailored to facilitate earlier access to new oral medicines. This dedicated issue of the J. Pharm. Pharmacol. hosts a collection of eleven review articles that showcase the research topics that are the focus of the PEARRL consortium. The objective of these review articles is to provide an up‐to‐date review on the current status of the target areas of research and to highlight approaches which can be used to streamline oral drug product. Each of the 15 ESRs in PEARRL contributed, both individually and collectively, to publishing these reviews. In addition, our industrial partners made significant contributions to these joint publications, which serves to highlight the industrial relevance of these reviews. Overall, 34 authors from 11 institutions within the PEARRL network were involved in preparing this special issue. We do hope you enjoy the read!
The full list of articles can be accessed from her:
THE PEARRL REVIEWS ‐ innovative drug development strategies tailored to facilitate earlier access to new oral medicines: Journal of Pharmacy and Pharmacology : Vol 71 , No 4 https://onlinelibrary.wiley.com/toc/20427158/2019/71/4